Global Male Infertility Market Insights Forecasts to 2033

• The Global Male Infertility Market Size was Valued at USD 3.79 Billion in 2023
• The Market Size is Growing at a CAGR of 3.49% from 2023 to 2033
• The Worldwide Male Infertility Market Size is Expected to Reach USD 5.34 Billion by 2033
• North America is expected to Grow the fastest during the forecast period.

The Global Male Infertility Market Size is Anticipated to Exceed USD 5.34 Billion by 2033, Growing at a CAGR of 3.49% from 2023 to 2033.

Market Overview

Male infertility is a condition in which a man is unable to impregnate a female partner because of problems connected to his reproductive system. It is frequently linked to problems with sperm production, quality, or delivery. As per the world health organization (WHO), failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse is called infertility. Male infertility can be caused by a low sperm count, inadequate sperm shape or motility, hormonal imbalances, genetic factors, and specific medical problems such as varicocele (enlarged scrotal veins). Lifestyle issues such as excessive alcohol use, smoking, drug usage, and obesity can all contribute to male infertility. Male infertility diagnosis involves techniques like DNA fragmentation, oxidative stress, CASA (computer-assisted semen analysis), sperm penetration assay, agglutination, and microscopic examination, with DNA fragmentation becoming popular in developed countries. The global increase in male infertility is driven by lifestyle changes, environmental pollutants, and stress, leading to increased demand for diagnostic and treatment solutions. Delaying parenthood for career goals and increased awareness about fertility issues have also boosted demand. Sedentary lifestyles, poor diets, and environmental toxins contribute to declining sperm quality and quantity. Advancements in medical technologies have improved diagnostic procedures and treatment outcomes.

Report Coverage

This research report categorizes the market for the global male infertility market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global male infertility market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global male infertility market.

Driving Factors

Increasing innovative technological advancements are increasing the demand of the global male infertility market during the forecast period. High adoption of assisted reproductive technology (ART) to boost the market growth. The global male infertility market is primarily driven by the rising incidence and prevalence of male infertility diseases. Some of the reasons include uneven morphology, low sperm concentration, and delayed sperm motility. Other variables that can contribute to male infertility include alcohol consumption, smoking, obesity, stress, and lifestyle changes. The advancing age is associated with a decline in male fertility, including decreased sperm quality and DNA fragmentation. Rising awareness and continuing advancements in the medical device sector to treat male infertility are projected to drive market growth throughout the forecast period. Hence, these factors are significant growth of the global male infertility market during the forecast period.

Restraining Factors

The high cost of treatment is the major factor to impedes the global male infertility market during the forecast period. The general population and healthcare professionals might face restraining factors due to limited or nonexistent insurance coverage for fertility treatments related to male infertility. Hence, these factors might hamper the market growth of the global male infertility market during the forecast period.

Market Segmentation

The global male infertility market share is classified into test, treatment, and end user.

• The DNA fragmentation technique segment is expected to hold the largest share of the global male infertility market during the forecast period.   

Based on the test, the global male infertility market is categorized into DNA fragmentation technique, and oxidative stress analysis. Among these, the DNA fragmentation technique segment is expected to hold the largest share of the global male infertility market during the forecast period. The segmental growth can be attributed to the DNA fragmentation techniques to provide the analysis of sperm DNA integrity. The market for sperm DNA fragmentation tests, which are crucial for male infertility, is expanding due to its increasing prevalence.

• The assisted reproductive technology segment is expected to grow at the fastest CAGR during the forecast period.   

Based on the treatment, the global male infertility market is categorized into assisted reproductive technology, varicocele surgery, and medication. Among these, the assisted reproductive technology segment is expected to grow at the fastest CAGR during the forecast period. Technology and techniques address a wide range of infertility therapies, providing solutions for men with issues such as low sperm count, poor sperm content, and poor motility. Technological advances in hormone treatment and medications, particularly assisted reproductive technology (ART), have led to high success rates, indicating a significant future expansion in male infertility demand. Thus, the segment is expected to grow at the fastest CAGR during the forecast period.

• The fertility centers segment is expected to hold a significant share of the global male infertility market during the forecast period.

Based on the end user, the global male infertility market is categorized into hospitals & clinics, fertility centers, research institutes, and others. Among these, the fertility centers segment is expected to hold a significant share of the global male infertility market during the forecast period. The segmental growth can be attributed to these centers being committed to delivering an extensive range of services that are tailored to individuals and couples dealing with reproductive issues. Fertility centers, staffed by specialists, provide comprehensive diagnostic evaluations, personalized treatment plans, and assisted reproductive technologies for male infertility, offering a supportive environment to address emotional and physical aspects.

Regional Segment Analysis of the Global Male Infertility Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Europe is anticipated to hold the largest share of the global male infertility market over the predicted timeframe.

Europe is projected to hold the largest share of the global male infertility market over the forecast period. The regional growth can be attributed to the availability of well-equipped and advanced fertility clinics, increased use of more expensive treatments, improved coverage for diagnosis and treatment, and a high level of knowledge. Healthcare spending and the availability of well-established healthcare infrastructure are key drivers of regional market growth. The growth of the fertility market in this region is driven by the geriatric population, diseases, and acceptance of minimally invasive procedures. The region's advanced healthcare infrastructure, coupled with changing socio-cultural dynamics, has led to increased awareness and acceptance of male infertility, prompting more individuals and couples to seek medical intervention.

North America is expected to grow at the fastest CAGR growth of the global male infertility market during the forecast period. The increasing elderly population, increased awareness of and availability of better healthcare facilities. As a result, the product is in high demand in this region. Posterity Health offers technology-enabled male fertility services, including at-home diagnostics and virtual visits, expected to drive market growth due to the increased adoption of at-home diagnostics.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global male infertility market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bayer Healthcare
• Andrology Solutions
• Endo International plc.
• Parallabs Ltd.
• MERCK KGaA
• Aytu BioScience, Inc.
• Cadila Healthcare Ltd.
• Halotech DNA SL
• EMD Sereno, Inc.
• Zydus Lifesciences Limited
• Cryolab Ltd.
• Sanofi
• SCSA Diagnostics, Inc.
• Vitrolife
• Intas Pharmaceuticals Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In November 2022, Sidra medicine has inaugurated a new male infertility clinic as part of its development into private reproductive health services in Qatar. As a result of the new male infertility clinic's launch, sidra medicine is now prepared to aid couples with comprehensive medical and surgical therapy.

• In June 2022, Hyderabad: oasis fertility launched the male fertility clinic ‘androlife’ at kompally. The newly launched clinic will cater to male infertility issues with the latest treatment such as Micro-TESE an advanced sperm retrieval procedure.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global male infertility market based on the below-mentioned segments: 

Global Male Infertility Market, By Test

• DNA Fragmentation Technique
• Oxidative Stress Analysis

Global Male Infertility Market, By Treatment

• Assisted Reproductive Technology
• Varicocele Surgery
• Medication

Global Male Infertility Market, By End User

• Hospitals & Clinics
• Fertility Centers
• Research Institutes
• Others

Global Male Infertility Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa